Growth Metrics

Incyte (INCY) Cash from Investing Activities Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 116.52%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 38.24%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -22.09%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 30.54%
10 Incyte 19.28 Bn 15.27 Bn 1.17 Bn -45.63%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -45.63%
Dec 31, 2025 -21.40%
Sep 30, 2025 -18.63%
Jun 30, 2025 -14.78%
Mar 31, 2025 27.35%
Dec 31, 2024 31.25%
Sep 30, 2024 46.88%
Jun 30, 2024 85.19%
Mar 31, 2024 -6.96%
Dec 31, 2023 -14.57%
Sep 30, 2023 -5.95%
Jun 30, 2023 44.42%
Mar 31, 2023 35.92%
Dec 31, 2022 11.36%
Sep 30, 2022 -62.77%
Jun 30, 2022 34.86%
Mar 31, 2022 11.98%
Dec 31, 2021 -22.31%
Sep 30, 2021 -22.37%
Jun 30, 2021 -132.27%
Mar 31, 2021 -27.95%
Dec 31, 2020 10.44%
Sep 30, 2020 22.32%
Jun 30, 2020 -5.05%
Mar 31, 2020 7.87%
Dec 31, 2019 5.88%
Sep 30, 2019 47.89%
Jun 30, 2019 40.59%
Mar 31, 2019 -41.85%
Dec 31, 2018 -99.75%
Sep 30, 2018 -5.52%
Jun 30, 2018 47.23%
Mar 31, 2018 21.32%
Dec 31, 2017 -243.83%
Sep 30, 2017 19.31%
Jun 30, 2017 -9.35%
Mar 31, 2017 -42.79%
Dec 31, 2016 -21.79%
Sep 30, 2016 -114.88%
Jun 30, 2016 -139.34%
Mar 31, 2016 241.82%
Dec 31, 2015 -108.45%
Sep 30, 2015 -293.87%
Jun 30, 2015 -208.40%
Mar 31, 2015 -462.56%
Dec 31, 2014 -45.63%
Sep 30, 2014 -311.71%
Jun 30, 2014 -274.14%
Mar 31, 2014 -1,157.60%
Dec 31, 2013 -121.23%
Sep 30, 2013 -46.95%
Jun 30, 2013 -53.59%
Mar 31, 2013 -28.39%